Niagen Bioscience, Inc. current report, 29 February 2016

Business Context and Reporting Period

This Form 8-K was filed by ChromaDex Corporation on March 3, 2016, reporting events occurring on February 29, 2016. The filing details a material definitive agreement entered into by ChromaDex Analytics, Inc., a wholly owned subsidiary, regarding its laboratory facilities in Boulder, Colorado.

Key Financial Metrics

This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. The financial data provided is limited to the terms of a lease amendment:

  • Lease Term Extension: Extended through April 30, 2023.
  • Monthly Base Rent: Ranges from $23,471.59 to $27,210.01 for the period May 1, 2016, to April 30, 2023.
  • Capital Improvements Reimbursement: Lessor to reimburse up to $40,000 for actual work or repairs.
  • Property Details: Approximately 12,415 square feet of office and laboratory space at 2830 Wilderness Place, Boulder, CO.

Material Changes

The primary material change is the extension of the lease term for the company's Boulder laboratory by approximately seven years. Additionally, the agreement shifts certain maintenance responsibilities (HVAC, roof) to the Lessor and introduces a reimbursement mechanism for repairs, which differs from the prior lease structure.

Outlook, Risks, and Management Commentary

The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of risks and contingencies beyond the standard incorporation by reference of the lease amendment. The agreement ensures continued occupancy of the laboratory space through 2023.

Investor Verification Checklist

  • Verify the total annualized rent obligation based on the stepped monthly rates provided.
  • Confirm the specific scope of "actual work or repairs" eligible for the $40,000 reimbursement.
  • Review the full text of the Third Addendum to Lease Agreement (Exhibit 10.1) for termination clauses or additional covenants.
  • Assess the impact of the extended lease term on the company's long-term operating expense structure.